日本实体器官移植前后患者对推荐疫苗接种政策的依从性:全国问卷调查
该研究于2022年9月至11月对日本全部221家注册实体器官移植设施开展网络问卷调查,应答率70.2%。调查显示各设施在移植前、后疫苗接种政策上存在差距,接种率因设施而异;应答设施中分别有64.9%和68.9%推荐减毒活疫苗和灭活疫苗。作者认为应提高接种计划效率,并推动国家卫生系统在公共补贴支持下降低疫苗费用。
要点
- 应答设施中推荐减毒活疫苗者占64.9%,推荐灭活疫苗者占68.9%。
- 纳入接种方案的疫苗比例:肺炎球菌疫苗13价31.7%、23价65.4%,乙型肝炎病毒疫苗67.3%,新型冠状病毒疫苗73.1%,流感疫苗73.1%,带状疱疹疫苗23.1%。
- 未接种原因包括移植前时间不足(60.3%)、费用负担(41.1%)、接种次数多(21.9%)等。
核心结论
- 日本全国各设施在移植前、后疫苗接种实践上存在差距。
- 作者认为应促进接种计划的效率,并鼓励国家卫生系统在公共补贴支持下降低疫苗费用。
研究设计与样本
- 研究为全国问卷调查,调查时间为2022年9月至11月。
- 对象为日本全部221家注册实体器官(肺、肝、肾、胰腺、心脏、小肠)移植设施,采用网络问卷。
- 应答率为70.2%。
主要发现
- 应答设施中推荐减毒活疫苗者占64.9%,推荐灭活疫苗者占68.9%。
- 纳入接种方案的疫苗比例:13价肺炎球菌结合疫苗31.7%,23价肺炎球菌多糖疫苗65.4%。
- 纳入接种方案的疫苗比例:乙型肝炎病毒疫苗67.3%,新型冠状病毒疫苗73.1%,流感疫苗73.1%,带状疱疹疫苗23.1%。
- 未接种原因:移植前时间不足60.3%,费用负担41.1%,接种次数多21.9%,未认识到接种必要性17.9%,需解释接种必要性15.2%。
关键数值与推荐
- 推荐减毒活疫苗的设施占64.9%,推荐灭活疫苗的设施占68.9%。
- 13价肺炎球菌结合疫苗纳入方案者31.7%,23价肺炎球菌多糖疫苗纳入方案者65.4%。
- 乙型肝炎病毒疫苗纳入方案者67.3%,新型冠状病毒疫苗73.1%,流感疫苗73.1%,带状疱疹疫苗23.1%。
- 未接种原因:移植前时间不足60.3%,费用负担41.1%,接种次数多21.9%,未认识到接种必要性17.9%,需解释接种必要性15.2%。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pre-transplant vaccination is recommended for patients undergoing solid organ transplantation (SOT). While appropriate vaccination protocols are implemented at some facilities, transplantation is sometimes performed with inadequate preoperative vaccine management. Vaccination rates vary across facilities, but those of SOT centers in Japan have never been investigated. This study aimed to conduct a nationwide questionnaire survey to assess pre- and post-transplant vaccination policies among SOT facilities in Japan. METHODS: The survey was conducted from September to November 2022. All registered (n = 221) solid organ (namely, the lungs, liver, kidneys, pancreas, heart, and small intestine) transplant facilities were asked to complete a web-based survey. RESULTS: The survey response rate was 70.2 %. Live and inactivated vaccines were recommended at 64.9 % and 68.9 % of the responding facilities, respectively. The following vaccines were incorporated into the vaccination protocols of facilities: pneumococcal vaccine, 31.7 % (13-valent pneumococcal conjugate vaccine) and 65.4 % (23-valent pneumococcal polysaccharide vaccine); hepatitis B virus vaccine, 67.3 %; severe acute respiratory syndrome coronavirus 2 vaccine, 73.1 %; influenza vaccine, 73.1 %; and zoster vaccines, 23.1 %. The reasons for unresponsiveness to vaccinations included inadequate time before transplantation (60.3 %), cost burden (41.1 %), high number of vaccinations (21.9 %), no recognition of the need for vaccination (17.9 %), and the requirement to explain the need for vaccination (15.2 %). CONCLUSIONS: Our study revealed gaps in vaccination practices across nationwide facilities in Japan. The findings indicate the importance of promoting scheduled efficiency and encouraging the national health system to reduce vaccine costs with the support of public subsidies.
引用
- Tanaka T, Kakiuchi S, Tashiro M, et al. Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: A national questionnaire survey in Japan. Vaccine. 2023. PMID: 38007343. doi:10.1016/j.vaccine.2023.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。